Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis.
Saved in:
| Title: | Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. |
|---|---|
| Authors: | Woudenberg T; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., van der Bent ML; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Kremer V; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands., Waas ISE; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands., Daemen MJAP; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands., Boon RA; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands.; Institute for Cardiovascular Regeneration, Centre for Molecular Medicine Goethe University, Frankfurt am Main, Germany.; German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany., Quax PHA; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Nossent AY; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2025 Sep; Vol. 182 (18), pp. 4221-4235. Date of Electronic Publication: 2024 Oct 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39419283 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Woudenberg+T%22">Woudenberg T</searchLink>; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Bent+ML%22">van der Bent ML</searchLink>; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kremer+V%22">Kremer V</searchLink>; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Waas+ISE%22">Waas ISE</searchLink>; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Daemen+MJAP%22">Daemen MJAP</searchLink>; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Boon+RA%22">Boon RA</searchLink>; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands.; Institute for Cardiovascular Regeneration, Centre for Molecular Medicine Goethe University, Frankfurt am Main, Germany.; German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Quax+PHA%22">Quax PHA</searchLink>; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nossent+AY%22">Nossent AY</searchLink>; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2025 Sep; Vol. 182 (18), pp. 4221-4235. <i>Date of Electronic Publication: </i>2024 Oct 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39419283 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.17374 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4221 Titles: – TitleFull: Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Woudenberg T – PersonEntity: Name: NameFull: van der Bent ML – PersonEntity: Name: NameFull: Kremer V – PersonEntity: Name: NameFull: Waas ISE – PersonEntity: Name: NameFull: Daemen MJAP – PersonEntity: Name: NameFull: Boon RA – PersonEntity: Name: NameFull: Quax PHA – PersonEntity: Name: NameFull: Nossent AY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5381 Numbering: – Type: volume Value: 182 – Type: issue Value: 18 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |